School of Laboratory Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Laboratory Medicine Center, Department of Transfusion Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, China.
Appl Microbiol Biotechnol. 2022 Oct;106(19-20):6671-6687. doi: 10.1007/s00253-022-12156-x. Epub 2022 Sep 9.
With the development of 16S rRNA technology, gut microbiome evaluation has been performed in many diseases, including gastrointestinal tumors. Among these cancers, gastric cancer (GC) exhibits high morbidity and mortality and has been extensively studied in its pathogenesis and diagnosis techniques. The current researches have proved that the gut microbiome may have the potential to distinguish GC patients from healthy patients. However, the change of the gut microbiome according to tumor node metastasis classification (TNM) has not been clarified. Besides, the characteristics of gut microbiome in GC patients and their ages of onset are also ambiguous. To address the above shortcomings, we investigated 226 fecal samples and divided them according to their tumor stage and onset age. The findings revealed that surgery and tumor stage can change the characteristic of GC patients' gut microbiota. In specific, the effect of surgery on early gastric cancer (EGC) was greater than that on advanced gastric cancer (AGC), and the comparison of postoperative microflora with healthy people indicated that EGC has more differential bacteria than AGC. Besides, we found that Collinsella, Blautia, Anaerostipes, Dorea, and Lachnospiraceae_ND3007_group expressed differently between EGC and AGC. More importantly, it is the first time revealed that the composition of gut microbiota in GC is different between different onset ages. KEY POINTS: •Gut microbiota of gastric cancer (GC) patients are either highly associated with TNM stage and surgery or not. It shows surgery has more significant changes in early gastric cancer (EGC) than advanced gastric cancer (AGC). •There existed specific gut microbiota between EGC and AGC which may have potential to distinguish the early or advanced GC. •Onset age of GC may influence the gut microbiota: the composition of gut microbiota of early-onset gastric cancer (EOGC) and late-onset gastric cancer (LOGC) is significantly different.
随着 16S rRNA 技术的发展,肠道微生物组评估已在许多疾病中进行,包括胃肠道肿瘤。在这些癌症中,胃癌(GC)发病率和死亡率较高,其发病机制和诊断技术已得到广泛研究。目前的研究已经证明,肠道微生物组可能有潜力将 GC 患者与健康患者区分开来。然而,根据肿瘤淋巴结转移分类(TNM)的肠道微生物组变化尚未阐明。此外,GC 患者肠道微生物组的特征及其发病年龄也不明确。为了解决上述缺点,我们研究了 226 个粪便样本,并根据肿瘤分期和发病年龄对其进行了划分。研究结果表明,手术和肿瘤分期会改变 GC 患者肠道微生物组的特征。具体来说,手术对早期胃癌(EGC)的影响大于对晚期胃癌(AGC)的影响,术后微生物群与健康人群的比较表明,EGC 比 AGC 有更多的差异细菌。此外,我们发现柯林斯氏菌、布劳特氏菌、拟杆菌属、多尔氏菌和lachnospiraceae_ND3007_group 在 EGC 和 AGC 之间表达不同。更重要的是,这是首次揭示 GC 患者肠道微生物组在不同发病年龄之间存在差异。关键点:•GC 患者的肠道微生物组与 TNM 分期和手术高度相关或不相关。结果表明,手术对早期胃癌(EGC)的影响大于对晚期胃癌(AGC)的影响。•在 EGC 和 AGC 之间存在特定的肠道微生物群,它们可能具有区分早期或晚期 GC 的潜力。•GC 的发病年龄可能会影响肠道微生物组:早发性胃癌(EOGC)和晚发性胃癌(LOGC)的肠道微生物组组成有显著差异。